Peroxiporin Expression Is an Important Factor for Cancer Cell Susceptibility to Therapeutic H(2)O(2): Implications for Pharmacological Ascorbate Therapy

Cancer cell toxicity to therapeutic H(2)O(2) varies widely depending on cell type. Interestingly, it has been observed that different cancer cell types have varying peroxiporin expression. We hypothesize that variation in peroxiporin expression can alter cell susceptibility to therapeutic H(2)O(2) c...

Descripción completa

Detalles Bibliográficos
Autores principales: Erudaitius, Dieanira, Huang, Andrew, Kazmi, Sarah, Buettner, Garry R., Rodgers, Victor G. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5249139/
https://www.ncbi.nlm.nih.gov/pubmed/28107421
http://dx.doi.org/10.1371/journal.pone.0170442

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5249139/
https://www.ncbi.nlm.nih.gov/pubmed/28107421
http://dx.doi.org/10.1371/journal.pone.0170442

Ejemplares similares